[1] Terheggen HG, Lowenthal A, Lavinha F, Colombo JP. Familial hyperargininaemia[J]. Arch Dis Child, 1975, 50(1): 57-62.

[2]  Cederbaum SD, Yu H, Grody WW, Kern RM, Yoo P, Iyer RK. Arginases I and II: do their functions overlap?[J]. Mol Genet Metab, 2004, 81(Suppl 1): S38-S44.

[3]  Lee BH, Jin HY, Kim GH, Choi JH, Yoo HW. Argininemia presenting with progressive spastic diplegia[J]. Pediatr Neurol, 2011, 44(3): 218-220.

[4]  Seminara J, Tuchman M, Krivitzky L, Krischer J, Lee HS, Lemons C. Establishing a Consortium for the Study of Rare Diseases: The Urea Cycle Disorders Consortium[J]. Mol Genet Metab, 2010, 100(Suppl 1): S97-105.

[5]  Deignan JL, Cederbaum SD, Grody WW. Contrasting features of urea cycle disorders in human patients and knockout mouse models[J]. Mol Genet Metab, 2008, 93(1): 7-14.

[6]  Nagata N, Matsuda I, Oyanagi K. Estimated frequency of urea cycle enzymopathies in Japan[J]. Am J Med Genet, 1991, 39(2): 228-229.

[7]  Burke W, Tarini B, Press NA, Evans JP. Genetic screening[J]. Epidemiol Rev, 2011, 33(1): 148-164.

[8]  Segawa Y, Matsufuji M, Itokazu N, Utsunomiya H, Watanabe Y, Yoshino M, et al. Long-term survival case of arginase deficiency with severe multicystic white matter and compound mutations[J]. Brain Dev, 2011, 33(1): 45-48.

[9]  Hertecant JL, Al-Gazali LI, Karuvantevida NS, Ali BR. A novel mutation in ARG1 gene is responsible for arginase deficiency in an Asian family[J]. Saudi Med J, 2009, 30(12): 1601-1603.

[10]    顾学范, 韩连书, 高晓岚, 杨艳玲, 叶军, 邱文娟. 串联质谱技术在遗传性代谢病高危儿童筛查中的初步应用[J]. 中华儿科杂志, 2004, 42 (6): 401-404..

[11]  Zytkovicz TH, Fitzgerald EF, Marsden D, Larson CA, Shih VE, Johnson DM, et al. Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England Newborn Screening Program[J] . Clin Chem, 2001, 47(11): 1945-1955.

[12]  Marsden D. Expanded newborn screening by tandem mass spectrometry: the Massachusetts and New England experience[J]. Southeast Asian J Trop Med Public Health, 2003, 34(Suppl 3): 111-114.

[13]  娄燕, 尹娜, 陈凤琴, 程亚颖, 徐丽瑾, 戴方, 等. 串联质谱技术选择性筛查遗传代谢病高危患儿552例初步分析[J]. 中国当代儿科杂志, 2011, 13(4): 296-299.

[14]  韩连书, 叶军, 邱文娟, 高晓岚, 王瑜, 金晶, 等. 串联质谱联合气相色谱-质谱检测遗传性代谢病[J]. 中华医学杂志，2008, 88(30): 2122-2126.

[15]  杨艳玲, 孙芳, 钱宁, 宋金青, 王爽, 常杏芝, 等. 尿素循环障碍的临床和实验室筛查研究[J]. 中华儿科杂志, 2005, 43(5): 331-334.

[16]  Carvalho DR, Brum JM, Speck-Martins CE, Ventura FD, Navarro MM, Coelho KE, et al. Clinical features and neurologic progression of hyperargininemia[J]. Pediatr Neurol, 2012, 46(6): 369-374.

[17] Scholl-Burgi S, Baumgartner Sigl S, Haberle J, Haberlandt E, Rostásy K, Ertl C, et al. Amino acids in CSF and plasma in hyperammonaemic coma due to arginase1 deficiency [J]. J Inherit Metab Dis, 2008, 31(Suppl 2): S323-328.

[18] 罗小平, 王慕逖. 遗传性代谢病的治疗[J]. 中华儿科杂志, 2003, 41 (4): 264-268.

[19] Cohen YH, Bargal R, Zeigler M, Markus-Eidlitz T, Zuri V, Zeharia A. Hyperargininemia: a family with a novel mutation in an unexpected site[J]. JIMD Rep, 2012, 5: 83-88.

[20] Gomes Martins E, Santos Silva E, Vilarinho S, Saudubray JM, Vilarinho L. Neonatal cholestasis: an uncommon presentation of hyperargininemia [J]. J Inhert Metab Dis, 2010, 33(Suppl 3): S503-S506.

[21] Scaglia F, Lee B. Clinical, biochemical, and molecular spectrum of hyperargininemia due to arginase I deficiency [J]. Am J Med Genet Part C, 2006, 142C (2): 113-120.

[22]  Hewson S, Clarke JT, Cederbaum S. Prenatal diagnosis for arginase deficiency: a case study [J]. J Inherit Metab Dis, 2003, 26(6): 607-610.

[23]  Jain-Ghai S, Nagamani SC, Blaser S, Siriwardena K, Feigenbaum A. Arginase I deficiency: severe infantile presentation with hyperammonemia: more common than reported?[J]. Mol Genet Metab, 2011, 104(1-2): 107-111.

[24]  Oldham MS, VanMeter JW, Shattuck KF, Cederbaum SD, Gropman AL. Diffusion tensor imaging in arginase deficiency reveals damage to corticospinal tracts[J]. Pediatr Neurol, 2010, 42(1): 49-52.

[25]  Deignan JL, De Deyn PP, Cederbaum SD, Fuchshuber A, Roth B, Gsell W, et al. Guanidino compound levels in blood, cerebrospinal fluid, and post-mortem brain material of patients with argininemia[J]. Mol Genet Metab, 2010, 100(Suppl 1): S31-36.

[26]  Gungor S, Akinci A, Firat AK, Tabel Y, Alkan A. Neuroimaging findings in hyperargininemia[J]. J Neuroimaging, 2008, 18(4): 457-462.

[27]  Jay A, Seeterlin M, Stanley E, Grier R. Case report of argininemia: the utility of the arginine/ornithine ratio for newborn screening (NBS)[J]. JIMD Rep, 2013, 9: 121-124.

[28]  Kuhara T, Inoue Y, Ohse M, Krasnikov BF, Cooper AJ. Urinary 2-hydroxy-5-oxoproline, the lactam form of α-ketoglutaramate, is markedly increased in urea cycle disorders[J]. Anal Bioanal Chem, 2011, 400(7): 1843-1851.

[29]  Kanda H, Sumi D, Endo A, Toyama T, Chen CL, Kikushima M, et al. Reduction of arginase I activity and manganese levels in the liver during exposure of rats to methylmercury: a possible mechanism[J]. Arch Toxicol, 2008, 82(11): 803-808.

[30]  陈红, 王德芬, 李立群. 高精氨酸血症的酶学诊断 [J]. 上海医学检验杂志, 1989, 4 (4): 215-216.

[31]  Korman SH, Gutman A, Stemmer E, Kay BS, Ben-Neriah Z, Zeigler M. Prenatal diagnosis for arginase deficiency by second-trimester fetal erythrocyte arginase assay and first-trimester ARG1 mutation analysis[J]. Prenat Diagn, 2004, 24(11): 857-860.

[32]  包美珍. 尿素循环障碍疾病 [J]. 国外医学内分泌学分册，2002, 22 (5): 276-279.

[33]   Carvalho DR, Brand GD, Brum JM, Takata RI, Speck-Martins CE, Pratesi R. Analysis of novel ARG1 mutations causing hyperargininemia and correlation with arginase I activity in erythrocytes[J].Gene, 2012, 509(1): 124-130. 

[34]  Vockley JG, Goodman BK, Tabor DE, Kern RM, Jenkinson CP, Grody WW, et al. Loss of function mutations in conserved regions of the human arginase I gene [J]. Biochem Mol Med, 1996, 59(1): 44-51.

[35]  Haraguchi Y, Aparicio JM, Takiguchi M,  Akaboshi I, Yoshino M, Mori M, et al. Molecular basis of argininemia. Identification of two discrete frame-shift deletions in the liver-type arginase gene[J]. J Clin Invest, 1990, 86(1): 347-350.

[36]  Grody WW, Klein D, Dodson A E, Kern RM, Wissmann PB, Goodman BK, et al. Molecular genetic study of human arginase deficiency[J]. Am J Hum Genet, 1992, 50(6): 1281-1290.

[37]  Uchino T, Haraguchi Y, Aparicio JM, Mizutani N, Higashikawa M, Naitoh H, et al. Three novel mutations in the liver-type arginase gene in three unrelated Japanese patients with argininemia[J]. Am J Hum Genet, 1992, 51(6): 1406-1412.

[38]  Haberle J, Koch HG. Genetic approach to prenatal diagnosis in urea cycle defects[J]. Prenat Diagn, 2004, 24(5): 378-383.

[39]  Uchino T, Snyderman SE, Lambert M, Qureshi IA, Shapira SK, Sansaricq C, et al. Molecular basis of phenotypic variation in patients with argininemia[J]. Hum Genet, 1995, 96(3): 255-260.

[40]  Cardoso ML, Martins E, Vasconcelos R, Vilarinho L, Rocha J. Identification of a novel R21X mutation in the liver-type arginase gene (ARG1) in four Portuguese patients with argininemia[J]. Hum Mutat, 1999, 14(4): 355-356.

[41]  Vockley JG, Tabor DE, Kern RM, Goodman BK, Wissmann PB, Kang DS, et al. Identification of mutations (D128G, H141L) in the liver arginase gene of patients with hyperargininemia [J]. Hum Mutat, 1994, 4(2): 150-154.

[42]    Edwards RL, Moseley K, Watanabe Y, Wong LJ, Ottina J, Yano S. Long-term neurodevelopmental effects of early detection and treatment in a 6-year-old patient with argininaemia diagnosed by newborn screening[J]. J Inherit Metab Dis, 2009, 32(Suppl 1): S197-200.

[43]    Mitchell S, Ellingson C, Coyne T, Hall L, Neill M, Christian N, et al. Genetic variation in the urea cycle: a model resource for investigating key candidate genes for common diseases[J]. Hum Mutat, 2009, 30(1): 56-60.

[44]    杨艳玲. 遗传代谢病的饮食与药物治疗[J]. 中国儿童保健杂志, 2011, 19(2): 102-103.

[45]  Boles RG, Stone ML. A patient with arginase deficiency and episodic hyperammonemia successfully treated with menses cessation[J]. Mol Genet Metab, 2006, 89(4): 390-391.

[46]  Romero PA, Stone E, Lamb C, Chantranupong L, Krause A, Miklos A, et al. SCHEMA designed variants of human arginase I & II reveal sequence elements important to stability and catalysis[J]. ACS Synth Biol, 2012, 1(6): 221-228.

[47]  Glazer ES, Piccirillo M, Albino V, Di Giacomo R, Palaia R, Mastro AA, et al. Phase II study of pegylated arginine eiminase for nonresectable and metastatic hepatocellular carcinoma[J]. J Clin Oncol, 2010, 28 (13): 2220-2226.

[48] McKay TR, Rahim AA, Buckley SM,  Ward NJ, Chan JK, Howe SJ, et al. Perinatal gene transfer to the liver[J]. Curr Pharm Des, 2011, 17(24): 2528-2541.

[49] Meyburg J, Das AM, Hoerster F, Lindner M, Kriegbaum H, Engelmann G, et al. One liver for four children: first clinical series of liver cell transplantation for severe neonatal urea cycle defects [J]. Transplantation, 2009, 87(5): 636-641.

[50] Hughes RD, Mitry RR, Dhawan A. Hepatocyte transplantation for metabolic liver disease: UK experience [J]. J R Soc Med, 2005, 98(8): 341-345.

[51]  Pietrosi G, Vizzini GB, Gruttadauria S, Gridelli B. Clinical applications of hepatocyte transplantation [J]. World J Gastroenterol, 2009, 15 (17): 2074-2077.

[52]  Meyburg J, Hoffmann GF. Liver, liver cell and stem cell transplantation for the treatment of urea cycle defects [J]. Mol Genet Metab, 2010, 100(Suppl 1): S77-S83.

[53]  唐湘凤, 栾佐. 造血干细胞移植治疗黏多糖病研究进展[J]. 实用儿科临床杂志, 2011, 26 (3): 162-165.

[54]  Greenberg AJ, McCormick J, Tapia CJ, Windebank AJ. Translating gene transfer: a stalled effort [J]. Clin Transl Sci, 2011, 4(4): 279-281.

[55]  Gau CL, Rosenblatt RA, Cerullo V, Lay FD, Dow AC, Livesay J, et al. Short-term correction of arginase deficiency in a neonatal murine model with a helper-dependent adenoviral vector [J]. Mol Ther, 2009, 17(7): 1155-1163.

[56]  孙振晓, 于相芬. 丙戊酸钠导致高氨血症及脑病的研究进展 [J]. 中华临床医师杂志(电子版), 2012, 6 (8): 2163-2164.

[57]  杨艳玲. 北京市可治疗性遗传性疾病的诊疗现状 [J]. 药品评价, 2011, 8(4): 4-8.